Sam Dawkins

Aug 14, 2024 | heart.bmj.com | Cara Barnes |Harish Sharma |James Gamble |Sam Dawkins

Optimised guideline-directed medical therapy (GDMT) for patients with VsMR is important as many patients will have a significant reduction in the severity of their MR following treatment.5 In recent years, there have been advances in GDMT for the management of heart failure with reduced ejection fraction (HFrEF), both in terms of the availability of additional medication and in optimising their delivery.

Oct 10, 2023 | bjcardio.co.uk | Jonathan Byrne |Daniel Blackman |Sam Dawkins |Robert Smith

Transcatheter edge-to-edge repair (TEER) was first performed in 2003, and is now established across the developed world as an effective, minimally invasive treatment option for patients with mitral regurgitation (MR). Multiple large registries have established the efficacy of mitral TEER in patients with primary or degenerative MR in whom surgery is considered prohibitive or high risk, while ongoing randomised-controlled trials will determine its role in younger and lower-risk patients.

Aug 22, 2023 | heart.bmj.com | Cara Barnes |Harish Sharma |James Gamble |Sam Dawkins

Management of secondary mitral regurgitation: from drugs to devices Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.